Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Special lenses or eyedrops: which slows nearsightedness better in kids?

NCT ID NCT05062031

Disease control Sponsor: Fondation Ophtalmologique Adolphe de Rothschild Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Aug 21, 2026 · Updated 2 times

Summary

This study tests whether special glasses called DIMS lenses can slow the worsening of nearsightedness (myopia) in children as well as low-dose atropine eyedrops do. About 242 children aged 6-12 with myopia will wear either DIMS lenses or regular glasses plus use atropine drops nightly for two years. The goal is to see which approach better controls eye growth and prescription changes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Atropine 0.05% eyedrops and Defocus Incorporated Multiple Segments (DIMS) lenses
What this could lead to
If successful, this could show that DIMS lenses alone are as effective as atropine eyedrops for controlling myopia in children, offering a drug-free option.
What could go wrong
This is a single-center study with 242 participants, and results may not apply to all children. Atropine can cause light sensitivity and blurred near vision, and DIMS lenses may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

116 people

The number who actually took part.

Started

Oct 2021

Finished

Feb 2026

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 14 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of myopia - measured under cycloplegia - defined by: 1. A sphere power between -1 and -6 Diopters, on at least one of the two eyes 2. AND a cylindrical power strictly inferior to 2 Diopters 3. AND a maximum refractive error strictly inferior to 8 Diopters in the flattest axis * Not benefiting and never having benefited from a myopia control strategy (orthokeratology, soft defocusing lenses, low concentration atropine eye drops, peripheral defocusing corrective lenses) * Written consent of both parents Exclusion Criteria: * History of genetic disease, or general condition suggesting a syndromic myopia (including an axial length greater than 27 mm) * Strabismus * Amblyopia defined by a best corrected visual acuity strictly inferior to 10/10 on one of the two eyes * Anisometropia defined by a difference of 2 Diopters or more between the two eyes (in spherical equivalent) * History of allergy to atropine * History of severe anaphylaxis * Optical correction with contact lenses * Previous ophthalmologic surgery of the cornea, lens, retina * History of glaucoma or any other chronic ophthalmological disease in the course of treatment (including vernal keratoconjunctivitis)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myopia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Myopia

Contacts and locations

Locations

  • Hôpital Fondation Adolphe de Rothschild

    Paris, 75019, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.